Table of Contents
SECTION I |
HEALTH APPRAISAL AND
RISK ASSESSMENT |
|
1 |
Benefits and Risks Associated with
Physical Activity |
2 |
|
Physical Activity
and Fitness Terminology |
2 |
|
Public Health
Perspective for Current Recommendations |
5 |
|
Benefits of Regular
Physical Activity and/or Exercise |
8 |
|
Risks Associated
with Exercise |
8 |
|
Sudden Cardiac Death
Among Young Individuals |
10 |
|
Exercise-Related Cardiac
Events in Adults |
11 |
|
Exercise Testing and
the Risk of Cardiac Events |
12 |
|
Risks of Cardiac
Events During Cardiac Rehabilitation |
12 |
|
Prevention of
Exercise-Related Cardiac Events |
12 |
|
References |
15 |
2 |
Preparticipation Health Screening and
Risk Stratification |
18 |
|
Preparticipation
Screening |
19 |
|
Self-Guided
Screening for Physical Activity |
19 |
|
Professionally
Guided Screening for Physical Activity |
22 |
|
Risk Stratification |
22 |
|
Undisclosed or
Unavailable Cardiovascular Disease Risk-Factor Information |
24 |
|
Known
Cardiovascular, Pulmonary, and Metabolic Disease |
25 |
|
Major Signs/Symptoms
Suggestive of Cardiovascular, Pulmonary, and Metabolic Disease |
25 |
|
Atherosclerotic
Cardiovascular Disease Risk Factors |
25 |
|
Exercise Testing and
Participation Recommendations Based on Risk Category |
31 |
|
Exercise Testing and
Testing Supervision Recommendations Based on Risk Category |
31 |
|
Risk Stratification
for Cardiac Patients |
37 |
|
References |
39 |
SECTION II |
EXERCISE TESTING |
|
3 |
Pre-Exercise Evaluations |
42 |
|
Medical History,
Physical Examination, and Laboratory Tests |
42 |
|
Blood Pressure |
46 |
|
Lipids and Lipoproteins |
48 |
|
Blood Profile
Analyses |
50 |
|
Pulmonary Function |
51 |
|
Contraindications to
Exercise Testing |
53 |
|
Informed Consent |
53 |
|
Participant
Instructions |
58 |
|
References |
58 |
4 |
Health-Related Physical Fitness
Testing and Interpretation |
60 |
|
Purposes of
Health-Related Fitness Testing |
60 |
|
Basic Principles and
Guidelines |
60 |
|
Pretest Instructions |
61 |
|
Test Order |
61 |
|
Test Environment |
62 |
|
Body Composition |
62 |
|
Anthropometric
Methods |
63 |
|
Densitometry |
69 |
|
Other Techniques |
70 |
|
Body Composition
Norms |
70 |
|
Cardiorespiratory Fitness |
71 |
|
The Concept of Maximal Oxygen Uptake |
72 |
|
Maximal versus Submaximal
Exercise Testing |
73 |
|
Modes of Testing |
74 |
|
Cardiorespiratory Test Sequence and
Measures |
80 |
|
Test Termination
Criteria |
82 |
|
Interpretation of
Results |
84 |
|
Muscular Strength
and Muscular Endurance |
85 |
|
Rationale |
87 |
|
Principles |
88 |
|
Muscular Strength |
90 |
|
Muscular Endurance |
93 |
|
Special
Considerations |
96 |
|
Flexibility |
98 |
|
A Comprehensive
Health Fitness Evaluation |
101 |
|
References |
102 |
5 |
Clinical Exercise Testing |
105 |
|
Indications and
Applications |
105 |
|
Diagnostic Exercise
Testing |
105 |
|
Exercise Testing for
Disease Severity and Prognosis |
106 |
|
Exercise Testing
After Myocardial Infarction |
107 |
|
Functional Exercise
Testing |
107 |
|
Exercise Test
Modalities |
111 |
|
Exercise Protocols |
112 |
|
Upper-Body Exercise
Testing |
113 |
|
Testing for Return
to Work |
113 |
|
Measurements During
Exercise Testing |
116 |
|
Heart Rate and Blood
Pressure |
116 |
|
Electrocardiographic Monitoring |
118 |
|
Subjective Ratings
and Symptoms |
120 |
|
Gas Exchange and Ventilatory
Responses |
121 |
|
Blood Gases |
121 |
|
Indications for
Exercise Test Termination |
122 |
|
Postexercise Period |
122 |
|
Imaging Modalities |
123 |
|
Exercise
Echocardiography |
123 |
|
Exercise Nuclear
Imaging |
123 |
|
Pharmacologic Stress
Testing |
129 |
|
Computed Tomography
in the Assessment of Coronary Artery Disease |
130 |
|
Supervision of
Exercise Testing |
131 |
|
References |
132 |
6 |
Interpretation
of Clinical Exercise Test Data |
135 |
|
Exercise Testing as
a Screening Tool for Coronary Artery Disease |
135 |
|
Interpretation of
Responses to Graded Exercise Testing |
136 |
|
Heart Rate Response |
139 |
|
Blood Pressure
Response |
139 |
|
Electrocardiograph
Waveforms |
140 |
|
Limiting Signs and
Symptoms |
143 |
|
Gas Exchange and Ventilatory
Responses |
144 |
|
Diagnostic Value of
Exercise Testing |
145 |
|
Sensitivity |
145 |
|
Specificity |
146 |
|
Predictive Value |
147 |
|
Comparison with
Imaging Stress Tests |
147 |
|
Prognostic
Applications of the Exercise Test |
147 |
|
References |
148 |
SECTION III |
EXERCISE
PRESCRIPTION |
|
7 |
General
Principles of Exercise Prescription |
152 |
|
Exercise Mode (Type) |
152 |
|
Components of the
Exercise Training Session |
153 |
|
Aerobic
(Cardiovascular Endurance) Exercise |
154 |
|
Quantity of
Exercise: How Much Exercise is Enough for Health/Fitness Benefits? |
154 |
|
Aerobic
(Cardiovascular) Exercise Mode (Type) |
163 |
|
The Components of
the Aerobic (Cardiovascular Endurance) Exercise Prescription: The FITT
Principle or Frequency, Intensity, Time, and Type of
Exercise |
165 |
|
Rate of Progression |
165 |
|
Muscular Fitness |
165 |
|
Frequency of
Resistance Exercise |
168 |
|
Types of Resistance
Exercises |
168 |
|
Volume of Resistance
Exercise (Repetitions and Sets) |
169 |
|
Resistance Exercise
Technique |
170 |
|
Progression/Maintenance |
170 |
|
Flexibility Exercise
(Stretching) |
171 |
|
Neuromuscular
Exercise |
174 |
|
Exercise Program
Supervision |
174 |
|
Strategies for Improving
Exercise Adoption and Maintenance |
175 |
|
References |
180 |
8 |
Exercise
Prescription for Healthy Populations and Special Considerations |
183 |
|
Pregnancy |
183 |
|
Exercise Testing |
183 |
|
Exercise Prescription |
184 |
|
Special
Considerations |
185 |
|
Children and
Adolescents |
187 |
|
Exercise Testing |
188 |
|
Exercise Prescription |
189 |
|
Special
Considerations |
189 |
|
Older Adult |
190 |
|
Exercise Testing |
191 |
|
Exercise Prescription |
192 |
|
Special
Considerations |
194 |
|
Environmental
Considerations |
194 |
|
Exercise in Hot
Environments |
194 |
|
Exercise in Cold
Environments |
198 |
|
Exercise in
High-Altitude Environments |
201 |
|
References |
204 |
9 |
Exercise
Prescription for Patients with Cardiac Disease |
207 |
|
Inpatient
Rehabilitation Programs |
207 |
|
Frequency |
210 |
|
Intensity |
210 |
|
Time (Duration) |
210 |
|
Progression |
210 |
|
Outpatient Exercise
Programs |
211 |
|
Exercise Prescription |
212 |
|
Types of Outpatient
Exercise Programs |
216 |
|
Special
Considerations |
216 |
|
Exercise
Prescription without a Preliminary Exercise Test |
218 |
|
Resistance Training
for Cardiac Patients |
219 |
|
Exercise Training
for Return to Work |
222 |
|
References |
222 |
10 |
Exercise
Prescription for Other Clinical Populations |
225 |
Arthritis |
225 |
|
Exercise Testing |
225 |
|
Exercise Prescription |
226 |
|
Cancer |
228 |
|
Exercise Testing |
228 |
|
Exercise Prescription |
231 |
|
Diabetes Mellitus |
232 |
|
Exercise Testing |
233 |
|
Exercise Prescription |
234 |
|
Disabilities |
237 |
|
Cerebral Palsy |
237 |
|
Spinal Cord Injuries |
241 |
|
Dyslipidemia |
244 |
|
Exercise Testing |
245 |
|
Exercise Prescription |
245 |
|
Human
Immunodeficiency Virus |
246 |
|
Exercise Testing |
246 |
|
Exercise Prescription |
247 |
|
Hypertension |
248 |
|
Exercise Testing |
248 |
|
Exercise Prescription |
249 |
|
Metabolic Syndrome |
250 |
|
Exercise Testing |
252 |
|
Exercise
Prescription/Special Considerations |
252 |
|
Overweight and
Obesity |
253 |
|
Exercise Testing |
253 |
|
Exercise Prescription |
254 |
|
Behavioral Weight
Loss Program Recommendations |
255 |
|
Osteoporosis |
256 |
|
Exercise Testing |
256 |
|
Exercise Prescription |
256 |
|
Peripheral Artery
Disease |
258 |
|
Exercise Testing |
259 |
|
Exercise Prescription |
259 |
|
Pulmonary Diseases |
260 |
|
Exercise Testing |
261 |
|
Exercise Prescription |
262 |
|
Renal Disease |
264 |
|
Exercise Testing |
264 |
|
Exercise Prescription |
265 |
|
References |
266 |
|
SECTION IV |
APPENDICES |
|
Appendix A |
Common
Medications |
274 |
Appendix B |
Medical
Emergency Management |
292 |
Appendix C |
Electrocardiogram
Interpretation |
302 |
Appendix D |
|
310 |
Index |
363 |
|